Trial · NCT04333472
Piclidenoson for Treatment of COVID-19
NCT04333472, Phase 2, Completed, Can-Fite BioPharma
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Piclidenoson for Treatment of COVID-19. Trials, record NCT04333472. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04333472
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Piclidenoson for Treatment of COVID-19
- NCT number
- NCT04333472
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 6 participants, actual
- Lead sponsor
- Can-Fite BioPharma
- Conditions
- COVID-19, Coronavirus Infection
- Interventions
- Piclidenoson, Placebo
- First posted
- 2020-04-03
- Last updated
- 2022-04-22
Source ClinicalTrials.gov
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of subjects alive and free of respiratory failure | 29 days | Proportion of subjects alive and free of respiratory failure (defined as need for non-invasive or invasive mechanical ventilation, high-flow oxygen, or extracorporeal membrane oxygenation) at Day 29 |
| Primary | Proportion of subjects discharged home alive | 29 days | Proportion of subjects alive and discharged to home without need for supplemental oxygen at Day 29 |
| Primary | Treatment-emergent adverse events (AEs) | 29 days | Proportion of patients experiencing AEs |
| Secondary | Clinical status | 29 days | • Clinical status at Day 29 on NIAID 8-point ordinal scale (NIH 2020): 1. Not hospitalized, no limitations 2. Not hospitalized, with limitations 3. Hospitalized, no active medical problems 4. Hospitalized, not on oxygen 5. Hospitalized, on oxygen 6. Hospitalized, on high-flow oxygen or noninvasive mechanical ventilation 7. Hospitalized, on mechanical ventilation or ECMO 8. Death |
| Secondary | Time to improvement | 29 days | Time (days) to improvement of 2 points on 7-point ordinal clinical scale |
| Secondary | Incidence of mechanical ventilation | 29 days | Proportion of patients who require mechanical ventilation |
| Secondary | Ventilator-free days | 29 days | Ventilator-free days to Day 29 |
| Secondary | Incidence of Intensive Care Unit (ICU) admission | 29 days | Proportion of patients who require ICU admission |
| Secondary | Duration of ICU stay | 29 days | Duration (days) of ICU stay |
| Secondary | Time to hospital discharge | 29 days | Time (days) to hospital discharge |
1 to 10 of 19Source ClinicalTrials.gov
See all 19 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04333472
GET https://conductscience.org/api/trials/v1/NCT04333472/registered